Telavancin Pharmacokinetics in Cystic Fibrosis Patients
Clinical trial NCT03172793 · COMPLETED
Trial details
- NCT number
- NCT03172793
- Sponsor
- Joseph L. Kuti, PharmD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2019-04-17
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.